Market revenue in 2023 | USD 488.2 million |
Market revenue in 2030 | USD 757.5 million |
Growth rate | 6.5% (CAGR from 2023 to 2030) |
Largest segment | Immunohistochemistry |
Fastest growing segment | Digital Pathology and Workflow |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Immunohistochemistry, In situ Hybridization, Primary & Special Staining, Digital Pathology and Workflow, Anatomic Pathology, Molecular Pathology |
Key market players worldwide | Roche Holding AG ADR, Abbott Laboratories, Thermo Fisher Scientific Inc, Siemens AG, Danaher Corp, BioMerieux SA, Qiagen NV, BD, Merck KGaA, GE Aerospace, Agilent Technologies Inc, Biogenex, Cell Signaling Technology, Bio SB, DiaGenic |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to tissue diagnostics market will help companies and investors design strategic landscapes.
Immunohistochemistry was the largest segment with a revenue share of 25.71% in 2024. Horizon Databook has segmented the Latin America tissue diagnostics market based on immunohistochemistry, in situ hybridization, primary & special staining, digital pathology and workflow, anatomic pathology, molecular pathology covering the revenue growth of each sub-segment from 2018 to 2030.
Latin American countries exhibit high growth potential for tissue diagnostics market. Owing to favorable government initiatives such as reforms for early cancer detection, free medical and hospital assistance and improved funding for research initiatives in countries of Latin America can be seen as an opportunity for tissue based diagnostic tools and devices segment.
The regional distribution of clinical trials is shifting from developed nations to developing nations, thereby attracting large pharmaceutical companies toward this region. This is further supplemented by the low cost associated with product development and other services and the emergence of new therapies and personalized medicines.
These factors encourage the number of global leaders to collaborate with local service providers, which leverage profound knowledge and therapeutic expertise to manage clinical trials. Most of the Latin America laboratories are certified by the College of American Pathologists.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America tissue diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America tissue diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account